Turnover
≈ €100,000 estimated
The micro format states no turnover.
MEDLAP
Lifetime
1 annual account with figurespeak €26,488 (2025)
€26,488
peak €19,999 (2025)
€19,999
peak €22,166 (2025)
€22,166
€8,645
Board1 name since 2025
1 director
Documentsfilings and deeds
24-09-202655 days late
2025micro format
Incorporation 23-05Dividend €8331 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€3,000 100 shares
2025 accounts filed 55 days after the deadline
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 11,278 companies had the same profile as MEDLAP has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,278 companies, not a prediction for MEDLAP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Incorporation
Founding capital of €3,000, 100 shares · Founder: · Appointment: (director) · published on 23-05-2025 · Gazette deed
First establishment
Rue des Arts 36, Nivelles
Official details
Source: KBO- Status
- Active since 21-05-2025Normal situation
- Activity
- “Exercice,en son nom et pour son compte,de la médecine par ses organes médecins légalement…” (deed in French)From the articles, 2 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.374.065.1021400 Nivelles, since 21-05-2025
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on MEDLAP
The 2025 annual accounts show equity of €22,166 and a net result of €19,999. The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDLAP
- What is the company number of MEDLAP?
- The company number of MEDLAP is 1023.567.556. The VAT number is the same number with BE in front: BE 1023.567.556.
- Where is MEDLAP based?
- The registered office is at Rue des Arts 36, 1400 Nivelles.Company details
- What is the legal form of MEDLAP?
- MEDLAP is a private limited company (BV).
- When was MEDLAP founded?
- MEDLAP was founded on 21-05-2025.
- Is MEDLAP still active?
- Yes, MEDLAP is an active enterprise in the KBO register.
- What is the turnover of MEDLAP?
- The turnover in financial year 2025 is ≈ €100,000. This figure is estimated from the gross margin of €26,488 and 3,276 comparable companies of the same size. It probably lies between €63,000 and €190,000. It is a rough estimate.Financials
- Is MEDLAP profitable?
- In financial year 2025, MEDLAP made a profit of €19,999.
- Where can I find the annual accounts of MEDLAP?
- MEDLAP filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.